-
1دورية أكاديمية
المؤلفون: Yuki Takeyasu, MD, Tatsuya Yoshida, MD, Ken Masuda, MD, Yuji Matsumoto, MD, Yuki Shinno, MD, Yusuke Okuma, MD, Yasushi Goto, MD, Hidehito Horinouchi, MD, Noboru Yamamoto, MD, Yuichiro Ohe, MD
المصدر: JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100636- (2024)
مصطلحات موضوعية: Non–small cell lung cancer, Epidermal growth factor receptor, EGFR TKI, Osimertinib, Central nervous system, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Yasunori Murata, MD, PhD, Shigeru Tanzawa, MD, PhD, Toshihiro Misumi, PhD, Hiroshige Yoshioka, MD, PhD, Eisaku Miyauchi, MD, PhD, Kiichiro Ninomiya, MD, PhD, Masafumi Takeshita, MD, PhD, Kensaku Ito, MD, PhD, Tatsuro Okamoto, MD, PhD, Shunichi Sugawara, MD, PhD, Yosuke Kawashima, MD, Kazuki Hashimoto, MD, Masahide Mori, MD, PhD, Akihiko Miyanaga, MD, PhD, Anna Hayashi, MD, Hisashi Tanaka, MD, PhD, Ryoichi Honda, MD, PhD, Masafumi Nojiri, MD, PhD, Yuki Sato, MD, Akito Hata, MD, Ken Masuda, MD, PhD, Toshiyuki Kozuki, MD, PhD, Takahisa Kawamura, MD, PhD, Takuji Suzuki, MD, PhD, Teppei Yamaguchi, MD, PhD, Kazuhiro Asada, MD, PhD, Satoshi Tetsumoto, MD, PhD, Hiroshi Tanaka, MD, PhD, Satoshi Watanabe, MD, PhD, Yukihiro Umeda, MD, PhD, Kakuhiro Yamaguchi, MD, PhD, Shoichi Kuyama, MD, PhD, Kosuke Tsuruno, MD, PhD, Yuki Misumi, MD, PhD, Hiroshi Kuraishi, MD, PhD, Ken Yoshihara, MD, PhD, Akira Nakao, MD, PhD, Akihito Kubo, MD, PhD, Toshihiko Yokoyama, MD, PhD, Kana Watanabe, MD, PhD, Nobuhiko Seki, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100593- (2023)
مصطلحات موضوعية: Necitumumab, Immune checkpoint inhibitor, Platinum rechallenge, Skin disorder, Lung squamous cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Yuki Takeyasu, MD, Tatsuya Yoshida, MD, Ken Masuda, MD, Yuji Matsumoto, MD, Yuki Shinno, MD, Yusuke Okuma, MD, Yasushi Goto, MD, Hidehito Horinouchi, MD, Noboru Yamamoto, MD, Yuichiro Ohe, MD
المصدر: JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100311- (2022)
مصطلحات موضوعية: Non–small cell lung cancer, Anaplastic lymphoma kinase, Lorlatinib, Chemotherapy, Pemetrexed, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Jiyun Lee, MD, Aaron C. Tan, BSc, M.B.B.S., PhD, FRACP, Siqin Zhou, MSc Statistics, Shinkyo Yoon, MD, PhD, Siyang Liu, MD, PhD, Ken Masuda, MD, Hidetoshi Hayashi, MD, PhD, Ullas Batra, MD, DM, Dong-Wan Kim, MD, PhD, Yasushi Goto, MD, PhD, Sze Huey Tan, PhD, Yi-Long Wu, MD, Dae Ho Lee, MD, PhD, Daniel S.W. Tan, BSc, M.B.B.S., MRCP, PhD, Myung-Ju Ahn, MD, PhD
المصدر: JTO Clinical and Research Reports, Vol 3, Iss 1, Pp 100261- (2022)
مصطلحات موضوعية: KRAS, Non–small cell lung cancer, Asian, Time to next treatment, Overall survival, Immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Masuda K; Ken Masuda, MD and Hiroto Ishiki, MD, National Cancer Center Hospital, Tokyo, Japan; Shunsuke Oyamada, MS, JORTC Data Center, Tokyo, Japan; and Masaki Shimizu, MD; Daisuke Kiuchi, MD; and Eriko Satomi, MD, National Cancer Center Hospital, Tokyo, Japan., Ishiki H; Ken Masuda, MD and Hiroto Ishiki, MD, National Cancer Center Hospital, Tokyo, Japan; Shunsuke Oyamada, MS, JORTC Data Center, Tokyo, Japan; and Masaki Shimizu, MD; Daisuke Kiuchi, MD; and Eriko Satomi, MD, National Cancer Center Hospital, Tokyo, Japan., Oyamada S; Ken Masuda, MD and Hiroto Ishiki, MD, National Cancer Center Hospital, Tokyo, Japan; Shunsuke Oyamada, MS, JORTC Data Center, Tokyo, Japan; and Masaki Shimizu, MD; Daisuke Kiuchi, MD; and Eriko Satomi, MD, National Cancer Center Hospital, Tokyo, Japan., Shimizu M; Ken Masuda, MD and Hiroto Ishiki, MD, National Cancer Center Hospital, Tokyo, Japan; Shunsuke Oyamada, MS, JORTC Data Center, Tokyo, Japan; and Masaki Shimizu, MD; Daisuke Kiuchi, MD; and Eriko Satomi, MD, National Cancer Center Hospital, Tokyo, Japan., Kiuchi D; Ken Masuda, MD and Hiroto Ishiki, MD, National Cancer Center Hospital, Tokyo, Japan; Shunsuke Oyamada, MS, JORTC Data Center, Tokyo, Japan; and Masaki Shimizu, MD; Daisuke Kiuchi, MD; and Eriko Satomi, MD, National Cancer Center Hospital, Tokyo, Japan., Satomi E; Ken Masuda, MD and Hiroto Ishiki, MD, National Cancer Center Hospital, Tokyo, Japan; Shunsuke Oyamada, MS, JORTC Data Center, Tokyo, Japan; and Masaki Shimizu, MD; Daisuke Kiuchi, MD; and Eriko Satomi, MD, National Cancer Center Hospital, Tokyo, Japan.
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Sep 01; Vol. 37 (25), pp. 2293-2294. Date of Electronic Publication: 2019 Jul 22.
نوع المنشور: Journal Article; Comment
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Mesothelioma* , Pleural Neoplasms*, Benzamides ; Double-Blind Method ; Humans ; Neurofibromin 2 ; Pyrazines ; Sulfonamides
Full Text via ClinicalKey 
Full Text Finder